首页> 外文期刊>Journal of the American College of Surgeons >Financial impact of surgical site infection after kidney transplantation: implications for quality improvement initiative design.
【24h】

Financial impact of surgical site infection after kidney transplantation: implications for quality improvement initiative design.

机译:肾脏移植后手术部位感染的财务影响:对质量改善计划的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Surgical site infection (SSI) after kidney transplantation has been associated with worse graft and patient survival. Although there are clinical incentives to reduce the incidence of SSI, it is unknown whether these are aligned with financial incentives for payers and providers. We use post-kidney transplant surgical site infection (SSI) to quantify the financial implications of surgical complications. The goal of this study was to quantify the financial costs of SSI after kidney transplantation and to determine the party bearing the brunt of these costs. STUDY DESIGN: This was a retrospective cohort study of all adult, first-time kidney-only transplant recipients at the University of Michigan Health System from September 2003 to April 2008 (n = 869). The primary exposure variable was SSI. SSI was defined as skin dehiscence, fascial dehiscence, or bowel evisceration. Primary outcomes measures were hospital revenue (payer costs), hospital inpatient costs, and hospital margin. We used simple univariate (t-test) analysis and multivariate (generalized linear regression) models to control for donor, recipient, and insurer characteristics. RESULTS: Eighteen percent of patients had documented SSIs. In cases with an SSI hospital revenue increased by Dollars 20,176, hospital margin decreased by Dollars 4,278, and hospital costs increased by Dollars 24,454. When adjusted for donor and recipient characteristics, SSI was independently associated with an Dollars 11,132 increase in hospital revenue. CONCLUSIONS: Although SSIs have negative financial effects on both hospitals and payers, the impact is greater on payers. Payers have the primary financial incentive to reduce SSI, and broad-based, quality improvement initiatives can be prudent investments for payers. Quantification of the costs associated with SSI can be used to define financial parameters for such initiatives that might prove beneficial to multiple stakeholders.
机译:背景:肾脏移植后的手术部位感染(SSI)与较差的移植物和患者的生存有关。尽管存在减少SSI发生率的临床诱因,但尚不清楚这些诱因是否与针对付款人和提供者的经济诱因相一致。我们使用肾脏移植后手术部位感染(SSI)来量化手术并发症的财务影响。这项研究的目的是量化肾脏移植后SSI的财务成本,并确定首当其冲的一方。研究设计:这是一项对2003年9月至2008年4月在密歇根大学卫生系统进行的所有成人首次肾脏移植的回顾性队列研究(n = 869)。主要的暴露变量是SSI。 SSI被定义为皮肤裂开,筋膜裂开或肠内脏脱落。主要结果指标是医院收入(付款人费用),住院病人费用和医院保证金。我们使用简单的单变量(t检验)分析和多元(广义线性回归)模型来控制捐赠者,接受者和保险人的特征。结果:18%的患者已记录了SSI。在SSI医院收入增加了20,176美元的情况下,医院保证金减少了4,278美元,而医院费用增加了24,454美元。当根据捐赠者和接受者的特征进行调整时,SSI独立地与医院收入增加11,132美元相关。结论:尽管SSI对医院和付款人都具有负面的财务影响,但对付款人的影响更大。付款人具有减少SSI的主要财务动机,而基础广泛的质量改进计划可以作为对付款人的审慎投资。与SSI相关的成本的量化可用于为此类计划定义财务参数,这可能证明对多个利益相关者有利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号